Cargando…
Lipopeptides against COVID-19 RNA-dependent RNA polymerase using molecular docking
BACKGROUND: Coronavirus disease 2019 (COVID-19) is caused by a novel virus that is responsible for the largest pandemic in recent times. Although numerous studies have explored methods to cope with COVID-19 and targeted drugs and vaccines have been developed, the spread of disease remains rapid due...
Autores principales: | Xia, Bo, Luo, Minyi, Pang, Li, Liu, Xia, Yi, Youjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chang Gung University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641408/ https://www.ncbi.nlm.nih.gov/pubmed/34871815 http://dx.doi.org/10.1016/j.bj.2021.11.010 |
Ejemplares similares
-
RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic
por: Tian, Lei, et al.
Publicado: (2021) -
Rational Drug Design and Docking of the RNA Dependent RNA Polymerase Domain of NCoV
por: Kumar, Amit, et al.
Publicado: (2020) -
Looking for inhibitors of the dengue virus NS5 RNA-dependent RNA-polymerase using a molecular docking approach
por: Galiano, Vicente, et al.
Publicado: (2016) -
Natural RNA dependent RNA polymerase inhibitors: Molecular docking studies of some biologically active alkaloids of Argemone mexicana
por: Pandeya, K.B., et al.
Publicado: (2020) -
Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics
por: Mohammed, Ahmed O., et al.
Publicado: (2022)